The table below shows the adverse reactions that happened in the participants
during the study.
Adverse reactions
Group 1 Group 2 Group 3
Adverse reaction (out of 179 participants) (out of 195 participants) (out of 201 participants)
Abnormal electrical activity 1.1% (2) 0.0% (0) 0.0% (0)
of the heart that affects its
rhythm
Diarrhea 0.0% (0) 0.5% (1) 0.0% (0)
Lip swelling 0.0% (0) 0.5% (1) 0.0% (0)
Nausea 0.0% (0) 0.5% (1) 0.0% (0)
Vomiting 0.0% (0) 0.5% (1) 0.0% (0)
Reaction to study treatment 0.0% (0) 0.5% (1) 0.0% (0)
Headache 0.0% (0) 0.5% (1) 0.0% (0)
Skin inflammation caused 0.0% (0) 0.5% (1) 0.0% (0)
by an allergy
Skin pain and rash 0.0% (0) 0.5% (1) 0.0% (0)
An itchy rash 0.0% (0) 0.5% (1) 0.0% (0)
How has this study helped patients and
researchers?
This study helped researchers learn more about how well MEDI6012 worked to
reduce the size of infarcts after a heart attack.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI6012 are not planned.
11 | Clinical Study Results